Mark S. Freedman

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double‐blind placebo‐controlled multicenter trial

Kathleen Hawker, Paul O’Connor, Mark S. Freedman et al. · Annals of Neurology · 2009 · 939 citations

Life Sciences, Neurology, Pharmacotherapy +15

A full genome search in multiple sclerosis

George C. Ebers, Kim Kukay, Dennis E. Bulman et al. · Nature Genetics · 1996 · 663 citations

Life Sciences, Genetics, Neurology +7

Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis

Martin Duddy, Masaaki Niino, Femina Adatia et al. · The Journal of Immunology · 2007 · 645 citations · Full text

Life Sciences, Immunology, Neurology +17

Quantifying axonal loss after optic neuritis with optical coherence tomography

Fiona Costello, Stuart G. Coupland, William Hodge et al. · Annals of Neurology · 2006 · 612 citations

Medicine, Neurology, Neuroscience +16

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.

Mark S. Freedman, Edward J. Thompson, Florian Deisenhammer et al. · PubMed · 2005 · 605 citations

Medicine, Neurology, Neuroscience +9